全文获取类型
收费全文 | 1757467篇 |
免费 | 126805篇 |
国内免费 | 4366篇 |
专业分类
耳鼻咽喉 | 23930篇 |
儿科学 | 58726篇 |
妇产科学 | 50140篇 |
基础医学 | 251639篇 |
口腔科学 | 48999篇 |
临床医学 | 154095篇 |
内科学 | 345690篇 |
皮肤病学 | 38826篇 |
神经病学 | 139843篇 |
特种医学 | 69189篇 |
外国民族医学 | 622篇 |
外科学 | 268548篇 |
综合类 | 40022篇 |
一般理论 | 615篇 |
预防医学 | 133322篇 |
眼科学 | 40290篇 |
药学 | 126608篇 |
3篇 | |
中国医学 | 3539篇 |
肿瘤学 | 93992篇 |
出版年
2018年 | 17987篇 |
2017年 | 14089篇 |
2016年 | 15650篇 |
2015年 | 17701篇 |
2014年 | 24622篇 |
2013年 | 38093篇 |
2012年 | 50478篇 |
2011年 | 53711篇 |
2010年 | 32445篇 |
2009年 | 30666篇 |
2008年 | 50900篇 |
2007年 | 53883篇 |
2006年 | 54584篇 |
2005年 | 53017篇 |
2004年 | 51171篇 |
2003年 | 49372篇 |
2002年 | 48170篇 |
2001年 | 80319篇 |
2000年 | 82488篇 |
1999年 | 69805篇 |
1998年 | 19570篇 |
1997年 | 17774篇 |
1996年 | 17769篇 |
1995年 | 16800篇 |
1994年 | 15799篇 |
1993年 | 14860篇 |
1992年 | 55569篇 |
1991年 | 53767篇 |
1990年 | 52870篇 |
1989年 | 50889篇 |
1988年 | 46688篇 |
1987年 | 46496篇 |
1986年 | 44060篇 |
1985年 | 42295篇 |
1984年 | 31674篇 |
1983年 | 26959篇 |
1982年 | 16197篇 |
1981年 | 14385篇 |
1979年 | 29414篇 |
1978年 | 20940篇 |
1977年 | 17766篇 |
1976年 | 16733篇 |
1975年 | 17953篇 |
1974年 | 21612篇 |
1973年 | 20787篇 |
1972年 | 19366篇 |
1971年 | 17957篇 |
1970年 | 16977篇 |
1969年 | 15867篇 |
1968年 | 14856篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
131.
Michiel R. de Boer Jos Twisk Annette C. Moll Hennie J. M. Völker-Dieben Henrica C. W. de Vet Ger H. M. B. van Rens 《Ophthalmic & physiological optics》2006,26(6):535-544
Consecutive patients (n = 215) who were referred to optometric (55%) or multidisciplinary (45%) low-vision services and above 50 years of age were recruited from four hospitals in the Netherlands. They completed two vision-related quality of life questionnaires, the Vision Quality of Life Core Measure (VCM1) and the Low Vision Quality of Life Questionnaire (LVQOL), before their first visit with low-vision services and 1 year later. At follow-up, patients referred to multidisciplinary low-vision services had lower scores on the mobility subscale of the LVQOL than patients referred to optometric low-vision services [5.3 points; 95% confidence interval (CI): 0.2-10.5]. Paired sample t-tests for the two groups of patients taken together show improvement for the VCM1 (3.1 points; 95% CI: 0.6-5.6) and deterioration for the basic aspects of vision (3.5 points; 95% CI: 1.1-5.9) and the mobility (6.6 points; 95% CI: 3.7-9.5) subscales of the LVQOL. In conclusion, people referred to optometric services showed less deterioration in mobility than those referred to multidisciplinary services. No differences were observed for any of the other subscales of the LVQOL and the VCM1. Future research in this field should include randomized controlled designs comparing low-vision services with no treatment or placebo. 相似文献
132.
133.
Rosario B Hidalgo Jerilyn Ross Jonathan R T Davidson 《Annals of clinical psychiatry》2006,18(3):157-162
BACKGROUND: Obsessive-compulsive disorder (OCD) is a chronic, impairing and often comorbid disorder. METHODS: 1000 subjects who called the Anxiety Disorders Association of America (ADAA) were surveyed and divided in three groups: (a) callers with OCD (OCD) and two overlapping control groups: (b) callers with no axis I disorder (NAC) and (c) with no-OCD (NOC) using a 97-item questionnaire. RESULTS: The rate of OCD was 14.5% (N = 145). Relative to the NOC group, OCD subjects were more likely to be female, White, younger and not married. Relative to the NAC group, subjects with OCD were more likely to be White, not married and younger. OCD was accompanied by significant comorbidity and was associated with an increased number of visits to health professionals than NAC subjects. There was no significant difference regarding unemployment rates among the three groups. However, OCD callers were more likely than both control groups to have missed work or have decreased productivity due to their mental condition. OCD subjects took an average of 1 psychotropic medication in the past year and were statistically more likely than the control groups to experience sleepiness and nervousness as side effects. CONCLUSIONS: OCD was fairly prevalent among ADAA callers and presented high levels of comorbidity, impairment, health care utilization and sensitivity to psychotropic side effects. 相似文献
134.
B Nkgudi K A Robertson J Volmink B M Mayosi 《Suid-Afrikaanse tydskrif vir geneeskunde》2006,96(3):206-208
OBJECTIVE: To determine whether under-reporting of rheumatic fever occurs at hospital, municipal, provincial and national levels of the South African health system. BACKGROUND: Information on the incidence of rheumatic fever (RF) and the prevalence of rheumatic heart disease (RHD) is required for the prevention of valvular heart disease in developing countries. In South Africa, RF was made a notifiable condition in 1989. It has recently been suggested that the reporting of RF cases may be incomplete, possibly because of underreporting by health care professionals and deficient administration of the disease notification system in South Africa. METHOD AND RESULTS: We assessed whether underreporting of RF cases occurs by comparing the numbers of RF cases reported per year at hospital, municipal, provincial and national levels from 1990 to 2004. There was a fall in the number of RF cases reported per year at national and provincial level over the 15 years of observation. A detailed analysis of the number of RF cases reported at hospital, municipal and provincial level for a 5-year period showed that more cases were diagnosed in one hospital (serving a smaller population) than were captured at municipal and provincial level (serving a larger population), suggesting underreporting by health care professionals. There were discrepancies in the number of cases reported at municipal, provincial and national level, suggesting poor administration of the notification system. CONCLUSION: There appears to be underreporting of RF cases by health care professionals, and poor administration of the RF notification system. Health care professionals need to be educated about the statutory requirement to notify all RF cases in South Africa. An effective national disease notification system is required. 相似文献
135.
136.
137.
Our group have studied a patient affected by a malignant schwannoma in the posterior tibial nerve. Schwannomas are uncommon neoplasms that originate from the Schwann cells of the peripheral nerves: the most common forms are benign. Malignant transformation is rarer. The therapy is surgical and the operation undertaken, if possible, should be the amputation. Alternatively, where amputation is not possible due to the specific localisation or due to patient refusal, the alternative must be the largest and most radical excision possible. 相似文献
138.
139.
R. H. Wiesner B. J. Steffen K. M. David A. H. Chu R. D. Gordon J. R. Lake 《American journal of transplantation》2006,6(7):1609-1616
Mycophenolate mofetil (MMF) used in a triple-drug regimen has been shown to decrease acute rejection rates, compared to a double-drug regimen. The impact of MMF on late acute rejection (LAR) episodes has not been well described. To investigate the risk of LAR (rejection > or = 6 months post-transplantation) data from the Scientific Registry of Transplant Recipients (SRTR) were used. We studied adult primary liver transplant recipients transplanted between June 1, 1995, and April 30, 2004, with hepatitis C virus (HCV) (n = 3356), hepatitis B virus (HBV) (n = 550) or a nonviral (n = 5740) primary cause of liver disease who were recorded as receiving continuous 3-(MMF + Tacro + steroids) versus 2-drug (Tacro + steroids) therapy for at least 6 months immediately post transplantation. Kaplan-Meier analysis showed significantly lower LAR rates 4 years post-transplant in 3- versus 2-drug HCV, HBV and nonviral disease patients. Multivariate regression confirmed 3- versus 2-drug therapy to be associated with a decreased risk of LAR. Late graft survival was significantly lower at 4 years post-transplant for patients with LAR 6-12 months post-transplantation versus patients with early rejection (78.0% vs. 87.0%, p < 0.001) and no rejection (88.1%, p < 0.001). Three-drug versus 2-drug therapy for a minimum of 6 months may offer a better treatment strategy to avoid the consequences and expense of LAR episodes. 相似文献
140.